Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2016 Nov-Dec;24(10):703–711. doi: 10.1097/PAI.0000000000000248

Table 4.

Characteristics of three patients who had high ORS but low RS using our formula

Patient #1 Patient #2 Patient #3
Age 63 67 63
Surgery Excision ALD Excision ALD Excision
ORS 35 34 38
RS using our formula 15.57 17.6 15.2
ER IHC (Allred score) 8 6 8
RT-PCR Positive (8.5)* Positive (11.1) Positive (9.8)
PR IHC (Allred score) 6 4 0
RT-PCR Positive (5.7) Negative (3.2) Negative (3.2)
Tumor size (mm) 9 8 38
Node status positive/total (N-stage) 1/8 (1mi) 1/3 (1mi) 0/9
Histology IC NST IC NST ILC
Nottingham grade II II III
TIL 1 0 1
Necrosis 0 0 0
Therapy Chemotherapy Cytoxan/Taxotere None** Cytoxan/Taxotere
Hormonal therapy Arimidex Arimidex Arimidex
Radiation therapy Post excision Post excision Post excision
Survival Alive and disease free (21 months) Alive and disease free (24 months) Bone metastases (28 months)
Alive after 57 months
*

Interpretation (ER Negative < 6.5, Positive ≥ 6.5; PR Negative < 5.5, Positive ≥ 5.5);

**

Declined chemotherapy;

ALD, axillary lymph node dissection; mi, micrometastases (>0.2-mm and <2-mm); IC NST, invasive carcinoma no special type; ILC, invasive lobular carcinoma; TIL, tumor infiltrating lymphocytes